Navigation Links
US trial shows no early mortality benefit from annual prostate cancer screening
Date:3/18/2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... Spring, PA (PRWEB) April 21, 2015 ... Berks County commercial printer, Offset Impressions. , ... its full line of printing capabilities and knowledgeable team ... “This acquisition allows us to offer an ever ... to the labeling, packaging, and specialty services we already ...
(Date:4/21/2015)... The California Healthcare Institute (CHI), ... sciences organizations, released the following statement by CHI ... Assembly Bill (AB) 463: , “As innovators in ... of treatments and cures for patients with serious ... AB 463, the so-called Pharmaceutical Cost Transparency Act ...
(Date:4/21/2015)... 2015 Information is the best weapon in ... FACP, empowers patients and their families with knowledge about living ... and Cancer is the Answer" and new website . ... to guide patients from diagnosis through treatment and even death. ... in their treatment, at home and in the examination room. ...
(Date:4/21/2015)... 21, 2015 The report ... comparative analysis on the therapeutic development for ... by identifying new targets and MOAs to ... with TOC is available @ http://www.rnrmarketresearch.com/dermatitis-pipeline-review-h1-2015-market-report.html ... key players involved in the therapeutic development ...
(Date:4/21/2015)... 2015 The 2015 Market Research ... a professional and in-depth study on the current ... with a focus on the Chinese situation. ... citrate market research are Cargill, Fbc Industries, Posy ... Biochemical, Capchem, Lianyungang Mupro Fi, Yixing-Union, Debang Fine ...
Breaking Medicine News(10 mins):Health News:California Healthcare Institute Statement on AB 463 2Health News:California Healthcare Institute Statement on AB 463 3Health News:Authoritative guide and new accompanying therapeutic web portal bridge information gaps in cancer treatment 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 2Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 3
... LONDON, Nov. 25 Cephalon, Inc.,(Nasdaq: CEPH ... today announced that the companies have signed an Option ... worldwide license to,the investigational medication Lupuzor(TM) for the treatment ... large Phase IIb study of,Lupuzor in patients in Europe ...
... Calif., Nov. 25 Peregrine,Pharmaceuticals, Inc. (Nasdaq: ... biopharmaceutical,company developing monoclonal antibodies for the treatment ... that the U.S. Patent and Trademark,Office has ... includes broad,claims covering anti-viral applications of antibodies ...
... ARNA ) announced today that the company is ... Conference on December 3, 2008 at 2:30,p.m. Eastern Time (11:30 ... York City. Jack Lief, Arena,s President and Chief Executive Officer, ... clinical,development and discovery programs. , ...
... a new,commercial finance company that will focus on middle market ... with over $500,million in equity commitments. MidCap,s investors are ... Moelis Capital Partners. MidCap,also has a substantial long-term debt ... Fargo & Company (NYSE: WFC ). , ...
... NEW YORK, Nov. 25 When Professional Basketball player Steve ... Gold Medal Snowboarder Gretchen Bleiler, Gold Medal Swimmer Amanda Beard and ... the slopes or enter an arena, it,s hard to ... , Besides being some of the world,s most accomplished ...
... Inc., a leader in the development and commercialization of ... the AIGISRx(TM) Anti-bacterial Envelope following its commercialization ... anti-bacterial surgical mesh developed to deliver anti-microbial agents that ... and cardioverter defibrillators. , ...
Cached Medicine News:Health News:Cephalon and ImmuPharma Sign a $15 million Option Agreement for Late- Stage Experimental Lupus Medication 2Health News:Cephalon and ImmuPharma Sign a $15 million Option Agreement for Late- Stage Experimental Lupus Medication 3Health News:Cephalon and ImmuPharma Sign a $15 million Option Agreement for Late- Stage Experimental Lupus Medication 4Health News:Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies 2Health News:Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies 3Health News:Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies 4Health News:Arena Pharmaceuticals to Present at the Piper Jaffray 20th Annual Health Care Conference 2Health News:Arena Pharmaceuticals to Present at the Piper Jaffray 20th Annual Health Care Conference 3Health News:MidCap Financial Launches Commercial Finance Company With Over $500 Million of Equity 2Health News:MidCap Financial Launches Commercial Finance Company With Over $500 Million of Equity 3Health News:MidCap Financial Launches Commercial Finance Company With Over $500 Million of Equity 4Health News:MidCap Financial Launches Commercial Finance Company With Over $500 Million of Equity 5Health News:Top Athletes Join Forces for a New Mission: Athlete-Engineered Skincare to Support Performance and Benefit Charity 2Health News:Top Athletes Join Forces for a New Mission: Athlete-Engineered Skincare to Support Performance and Benefit Charity 3Health News:TYRX, Inc. Announces 1,000th Implant of AIGISRx(TM) Anti-Bacterial Envelope 2Health News:TYRX, Inc. Announces 1,000th Implant of AIGISRx(TM) Anti-Bacterial Envelope 3Health News:TYRX, Inc. Announces 1,000th Implant of AIGISRx(TM) Anti-Bacterial Envelope 4
(Date:4/21/2015)... -- Organovo Holdings, Inc. (NYSE MKT: ONVO) today announced preliminary ... year ended March 31, 2015. Based on ... March 31, 2015, Organovo estimates: , Total ... and approximately $571 thousand for the fiscal year , ... and fiscal year ended March 31, 2015 of approximately ...
(Date:4/21/2015)... 21, 2015 Algae International Group, Inc. ( ALGA ... Company, today announced exceptional Hempster T-Shirt sales following yesterday,s ... Oil Company has introduced four t-shirt designs specific to ... the profit from the online sales of these first ... will be donated to the  Marijuana Policy Project  (MPP), ...
(Date:4/21/2015)... 21, 2015 Global cap & ... demand for caps and closures will exceed $55 billion in ... two trillion annually. Beverages will continue to account for well ... a number of smaller markets are expected to register faster ... Although the most developed markets -- the US, ...
Breaking Medicine Technology:Organovo Holdings, Inc. Pre-Announces Preliminary Fiscal 2015 Fourth Quarter And Year End Financial Information 2Organovo Holdings, Inc. Pre-Announces Preliminary Fiscal 2015 Fourth Quarter And Year End Financial Information 3Organovo Holdings, Inc. Pre-Announces Preliminary Fiscal 2015 Fourth Quarter And Year End Financial Information 4American Seed & Oil Company 420 Hempster T-Shirt Sales Soar; Online Sales Launched Yesterday with Start of 420 Week; Over 2000 Shirts Sold So Far 2World Caps & Closures Market 2World Caps & Closures Market 3
... proud to announce its conference keynote speakers include: Centers ... CBS Evening News Anchor Katie Couric; U.S. ... U.S. Secretary of Commerce Gary Locke. Each will address ... leaders in Washington, D.C. October 18-20 during AdvaMed ...
... Arlington Medical Resources (AMR), a provider of premier ... finds that more than half of all European inpatients ... Sanofi-Aventis,s Clexane (marketed as Lovenox in the U.S. and ... The European Hospital Anticoagulant Market Guide is a ...
Cached Medicine Technology:AdvaMed 2010 Keynote Speakers Announced 2AdvaMed 2010 Keynote Speakers Announced 3European Hospital Anticoagulant Market Dominated by Sanofi-Aventis's Clexane 2
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio...
This large 1000 L tip makes pipetting fragile cells, genomic DNA, and viscous samples easy. Perfect for cell culture laboratories....
300 L, Bulk Recommended for 250 and 300 L pipettes....
Designed to fit a variety of 250 L and 300 ul multi-channel pipettors, this tip offers a secure fit and extra space for repeat pipetting....
Medicine Products: